This inventor holds 2 USPTO granted patents. Top assignee: City University of Hong Kong. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: Innovations by Shenghui Xu in Medical Treatments
Introduction
Shenghui Xu is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of medical treatments, particularly in addressing mental disorders and epilepsy. With a total of 2 patents, his work focuses on innovative methods and compositions that aim to improve patient outcomes.
Latest Patents
Shenghui Xu's latest patents include a method and composition for treating mental disorders and pain associated with nerve damage. This method involves administering an effective amount of a cholecystokinin-2 receptor antagonist or a pharmaceutical acceptable salt thereof to the subject. Additionally, he has developed a pharmaceutical composition that includes the cholecystokinin-2 receptor antagonist as an active ingredient, along with one or more antidepressant compounds and a pharmaceutically acceptable excipient. Another significant patent is a method for treating epilepsy, which also utilizes the cholecystokinin-2 receptor antagonist to provide relief to patients suffering from this condition.
Career Highlights
Shenghui Xu is affiliated with the City University of Hong Kong, where he continues to engage in research and development in the medical field. His innovative approaches have the potential to transform treatment protocols for various neurological conditions.
Collaborations
Shenghui Xu collaborates with esteemed colleagues, including Jufang He and Xu Zhang, to further advance research in his area of expertise.
Conclusion
Shenghui Xu's contributions to medical innovations highlight the importance of research in developing effective treatments for mental disorders and epilepsy. His work exemplifies the impact of dedicated inventors in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
